Abstract:
PURPOSE: A pharmaceutical composition containing phenyltetrazole derivatives for preventing or treating osteoporosis, obesity, diabetes or hyperlipidemia is provided to control TAZ(transcriptional coactivator with PDZbinding motif) protein. CONSTITUTION: A pharmaceutical composition for preventing or treating osteoporosis contains a compound of chemical formula 1 or pharmaceutically acceptable salt thereof as an active ingredient. A pharmaceutical composition for preventing or treating obesity, diabetes or hyperlipidemia contains the compound of chemical formula 1 or pharmaceutically acceptable salt thereof as an active ingredient. The compound is phenyltetrazole derivatives.
Abstract:
PURPOSE: A carboxamide derivative is provided to bactericidal activity against plant epidemic, especially tomato epidemic and to have no crossed resistance to existing fungicide. CONSTITUTION: A carboxamide derivative has a structure of chemical formula 1 or optical isomer. In chemical formula 1, V is H or C2-C10 alkanyl, W is substituted or unsubstituted C6-C14 aryl or C7-C20 aryloxyalkyl or C1-C12 heteroaryl containing at least one N, S or O in a ring; n is an integer of 0-4; m is 0 or 1; R1, R2, R3 and R4 are independently H or C1-C6 alkyl; X is O, NH or S; Y is H or halogen; and Z is H or C1-C6 alkyl substituted or unsubstituted with cyano or C6-C12 aryl, or C2-C10 alkynyl.
Abstract:
본 발명은 하기 화학식 1로 표시되는 트라이아졸 유도체, 이의 제조 방법 및 이를 포함하는 약학적 조성물에 관한 것으로, 본 발명의 화학식 1의 화합물은 칸디다 알비칸(Candida albicans), 토룰롭시스(Torulopsis), 크립토코커스(Crytococcus), 아스퍼질러스(Aspergillus), 트라이코파이톤(Tricophyton) 및 플루코나졸(Fluconazole) 내성 칸디다 알비칸 등의 다양한 병원균에 대한 항진균 활성을 가지며, 종래의 항진균제보다 독성을 경감시키므로, 진균류의 감염 치료제로서 유용하게 사용될 수 있다.
Abstract:
A beta-aminoalcohol derivatives or pharmaceutically acceptable salts thereof are provided to inhibit the secretion of tumor necrosis factor-alpha(TNF-alpha), thereby preventing and treating TNF- alpha mediated disease. The beta-aminoalcohol derivatives represented by the chemical formula(1) or pharmaceutically acceptable salts thereof are useful for preventing and treating TNF- alpha mediated disease, wherein R1 is C4-C10 aryl or heteroaryl unsubstituted or substituted by 1 or 2 or more halogen, or C5-C10 cycloalkyl unsubstituted or substituted by 1 or 2 or more halogen; R2 is C4-C10 aryl or heteroaryl which is unsubstituted or substituted by 1 or 2 or more C1-C3 linear or branched alkyl, cyano or halogen; R3 is H or C1-C4 linear or branched alkyl; m is an integer from 0 to 3; and n is an integer from 1 to 5.
Abstract:
A method for preparing phenanthrene derivatives is provided to obtain various phenanthrene derivatives useful in various industrial fields with high yield in a simple manner. A method for preparing phenanthrene derivatives comprises a step of reacting a compound represented by the following formula 2 with a compound represented by the following formula 3 in a solvent in the presence of a palladium compound and a base. In the formulae, Y is C=O or SO2; R1 is H, OH, C1-C6 alkyl, C1-C6 alkoxy, NR11R12, or substituted or non-substituted C3-C7 aryl, or Y-R1 is cyano, if appropriate; each of R2, R3, R4, R5, R6, R7, R8 and R9 is H, halogen, OH, cyano, nitro, NR11R12, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C2-C8 alkenyl, C2-C4 alkynyl, C3-C8 cycloalkyl, C1-C4 alkoxy, C1-C4 alkyl, C3-C8 cycloalkoxy-C1-C4 alkyl, C1-C6 alkoxycarbonyl, C1-C6 alkylaminocarbonyl or C1-C8 alkylsulfonyl; R10 is H, OH, C1-C6 alkyl, C1-C6 haloalkyl, or substituted or non-substituted C3-C7 aryl; each of R11 and R12 is H, C1-C6 alkyl, C1-C6 alkoxy or C3-C7 cycloalkyl, or R11 and R12 form a 3- to-7-membered non-aromatic heterocyclic ring together with the nitrogen atom to which they are attached; aromatic rings A and D each represent a heteroaryl; and each of X and M represents a selected from halogen, C1-C6 alkylsulfonyloxy and arylsulfonyloxy, or b selected from B(OH)2 and B(OR13)2, wherein R13 is C1-C4 alkyl or two R13s are linked to each other to form a methyl-substituted heterocyclic ring together with B and O, with the proviso that when X is a, M is b, and when x is b, M is a.
Abstract:
The present invention relates to a catalyst for preparing 1,3-diphenyl-2-butene type compound represented by the following formula 1. The catalyst has a selective C-C bond forming specificity, and illustrates high transformation ratio to a target compound with high selectivity. Thus, the catalyst of the present invention can be favorably used in a process for preparing 1,3-diphenyl-2-butene type compound.
Abstract:
PURPOSE: An indazole derivative or salt thereof and an insecticidal composition containing the same are provided to eliminate various pests. CONSTITUTION: An indazole derivative is denoted by chemical formula 1. In chemical formula 1, A is N or CH; n and m are individually integer 0-4; V and W are individually hydroxyl, cyano, halogen, C1-6 alkyl, or C1-6 alkoxy; and X, Y, and Z are individually H, hydroxyl, cyano, halogen, C1-6 alkyl, C1-6 alkoxy, , -C(=O)-NH-R1, or -NHC(=O)-O-R2. An insecticidal composition contains the compound of chemical formula 1 as an active ingredient. A method for illuminating mite or insects comprises a step of treating the compound of chemical formula 1 to crops or habitat thereof.